Author: Wendie A. Berg, MD, PhD, FACR, FSBI
Interest in nuclear medicine-based breast imaging is increasing as advances in technology allow for lower dose of radiotracer and confirm high sensitivity for the detection of in-breast cancers. These tools may have roles as we develop tailored breast imaging in our efforts to provide personalized, value-based care for our patients.
Aunt Minnie (4/28) reports treating inflammatory breast cancer with traditional triple-modality therapy resulted in a 95.5% five-year survival rate with no local recurrence, according to a study presented at the American Society of Breast Surgeons’ annual meeting. Researchers found that 113 of 114 patients with inflammatory breast cancer who “were treated with chemotherapy prior to mastectomy and postsurgical radiation...had clear margins with no disease remaining at mastectomy tissue edges” in their post-treatment pathology reports.
Aunt Minnie (4/26) reports that Nebraska Gov. Pete Ricketts (R) “has signed a breast density notification bill into law.” The law “goes into effect on September 2.”
Aunt Minnie (4/27, Barnes) reports a team at Duke University Medical Center built a “photon-counting detector breast CT scanner” that “reliably imaged geometric phantoms that included biological material, and reliably reproduced attenuation coefficients and properties of materials,” according to research presented at ECR 2017 last month. The article reports that the system “acquired images at a radiation dose comparable to that of film-screen mammography.”
HealthDay (4/22, Doheny) reported that a study suggests “breast-milk analysis may someday offer an alternative to mammograms for women in their childbearing years.” Study first author Roshanak Aslebagh said, “We have found alterations in protein expression in the breast milk of women with breast cancer compared to women without breast cancer.” The findings were presented at the American Society for Biochemistry and Molecular Biology’s annual meeting.